Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
113.29
+2.54 (2.29%)
Aug 12, 2025, 4:00 PM - Market closed
Paramount Global Market Cap
Jazz Pharmaceuticals has a market cap or net worth of $6.87 billion as of August 12, 2025. Its market cap has increased by 0.21% in one year.
Market Cap
6.87B
Enterprise Value
10.56B
1-Year Change
0.21%
Ranking
Category
Stock Price
$113.29
Market Cap Chart
Since June 1, 2007, Jazz Pharmaceuticals's market cap has increased from $435.30M to $6.87B, an increase of 1,478.69%. That is a compound annual growth rate of 16.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 6.75B | -9.32% |
| Dec 31, 2024 | 7.45B | -3.86% |
| Dec 29, 2023 | 7.74B | -22.80% |
| Dec 30, 2022 | 10.03B | 28.09% |
| Dec 31, 2021 | 7.83B | -14.84% |
| Dec 31, 2020 | 9.20B | 8.89% |
| Dec 31, 2019 | 8.45B | 12.94% |
| Dec 31, 2018 | 7.48B | -7.37% |
| Dec 29, 2017 | 8.07B | 23.62% |
| Dec 30, 2016 | 6.53B | -24.46% |
| Dec 31, 2015 | 8.64B | -12.72% |
| Dec 31, 2014 | 9.90B | 35.42% |
| Dec 31, 2013 | 7.31B | 137.27% |
| Dec 31, 2012 | 3.08B | 89.28% |
| Dec 30, 2011 | 1.63B | 112.63% |
| Dec 31, 2010 | 765.90M | 213.64% |
| Dec 31, 2009 | 244.20M | 340.00% |
| Dec 31, 2008 | 55.50M | -84.62% |
| Dec 31, 2007 | 360.90M | -17.09% |
| Jun 1, 2007 | 435.30M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.77B |
| Johnson & Johnson | 415.56B |
| AbbVie | 349.44B |
| UnitedHealth Group | 236.02B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.97B |
| Novo Nordisk | 223.00B |